MENU

ALIM Alimera Sciences Forecast, Technical & Fundamental Analysis

Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the U... Show more

Industry: #Biotechnology
Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Articles
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY779.094.26
+0.55%
State Street SPDR S&P 500 ETF (SPY)
TSLA380.681.95
+0.51%
Tesla
AAPL333.630.74
+0.22%
Apple
BTC.X85557.560000-229.031250
-0.27%
Bitcoin cryptocurrency
GME24.76-0.48
-1.90%
GameStop Corp
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry PharmaceuticalsOther

Industry
Biotechnology
Address
6310 Town Square
Phone
+1 678 990-5740
Employees
159
Web
https://www.alimerasciences.com
Alimera Sciences (ALIM) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com